VERTEX PHARMACEUTICALS INC / MA: accounts_receivable
| Value | {"amount": 183135000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2011-12-31) |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:18.745941+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1ee7e489-6436-41f8-ba48-57237a68f1b1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-12-001298Retrieved: 2026-08-19T08:42:18.745941+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/accounts-receivable/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1ee7e489-6436-41f8-ba48-57237a68f1b1
History
- no predecessors — first report